Tagged with Regulation,

Mátyás Szentiványi – Director General, National Institute of Pharmacy and Nutrition (OGYEI), Hungary
US FDA’s Efforts to Advance the Development of Gene Therapy
ICER Strikes Again: Scandal Time?
Mike Braun – Partner, Deloitte China
3 Regulatory Trends Impacting UAE Healthcare
4 Top Pilot Programs in Chinese Pharma
Tares Krassanairawiwong – Secretary-General, Thai FDA
Sweden: Life Sciences Top of the Political Agenda
Speeding up Regulatory Submissions Through Continuous Publishing
Jenni Nordborg – Director & National Coordinator, Life Sciences Office Sweden
Yu-Ih Hou – Mayor, New Taipei City, Taiwan
The Liberalization of the Cultivation and Production of Medical Cannabis in Croatia
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here